MedTrace Logo

Austrian Wearable Cardioverter Defibrillator Registry

NCT02816047 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 450

Last updated 2021-09-14

No results posted yet for this study

Summary

Background: The wearable cardioverter defibrillator (WCD) is an established treatment option for patients at high risk for ventricular tachycardia / ventricular fibrillation (VT/VF), either in whom this risk may only be temporarily present, or in patients at high risk for sudden cardiac death (SCD) or after VT/VF in whom an implantable cardioverter defibrillator (ICD is currently not possible for other reasons (infection, recent MI \<40days, recent PCI/CABG \< 3months etc.).

Methods: Comprehensive registry including all patients in Austria who received a WCD in 2010-2016.

Conditions

  • Heart Failure
  • Ventricular Dysfunction
  • Sudden Death
  • Sudden Cardiac Arrest
  • Ventricular Tachycardia
  • Ventricular Fibrillation

Interventions

OTHER

Registry

Observational study to describe WCD indications, event rates, inappropriate shock rates and follow up (including ICD rate, shock rate, morbidity and mortality) in all Austrian WCD patients

Sponsors & Collaborators

  • Medical University of Graz

    lead OTHER

Principal Investigators

  • Daniel Scherr, Assoz. Prof. · Medical University of Graz/ Division of Cardiology

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-11-30
Primary Completion
2021-12-31
Completion
2022-03-31

Countries

  • Austria

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02816047 on ClinicalTrials.gov